- Polycytidylic Acid
-
- $150.00 / 1kg
-
2025-04-25
- CAS:24939-03-5
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 500kg
|
| Polyinosinic acid-polycytidylic acid Basic information |
Product Name: | Polyinosinic acid-polycytidylic acid | Synonyms: | POLY(I) POLY(C);POLYINOSINIC ACID POLYCYTIDYLIC ACID;POLYINOSINIC POLYCYTIDYLIC ACID;polyinosinic:polycytidylic acid copolymer;POLYCYTIDYLIC-INOSINIC ACID;Polyinosinic-polytidylin Acid.;POLYINOSINIC ACID . POLYCYTIDYLIC ACID, LYOPHILIZED;POLYCYTIDYLIC-INOSINIC ACID POTASSIUM | CAS: | 24939-03-5 | MF: | C19H27N7O16P2 | MW: | 671.41 | EINECS: | 1308068-626-2 | Product Categories: | Material | Mol File: | 24939-03-5.mol |  |
| Polyinosinic acid-polycytidylic acid Chemical Properties |
storage temp. | Inert atmosphere,Store in freezer, under -20°C | solubility | Water (Slightly) | form | Solid | color | White to Off-White | Water Solubility | Soluble to 3 mg/ml in water | Stability: | Hygroscopic | InChIKey | ACEVNMQDUCOKHT-WOQDZEJINA-N | SMILES | O[C@@H]1[C@@H]([C@@H](COP(O)(O)=O)O[C@H]1N1C=CC(N)=NC1=O)O.O[C@@H]1[C@@H]([C@@H](COP(O)(O)=O)O[C@H]1N1C=NC2C(NC=NC1=2)=O)O |&1:1,2,3,11,22,23,24,32,r| |
WGK Germany | 3 | RTECS | TR0175000 |
| Polyinosinic acid-polycytidylic acid Usage And Synthesis |
Uses | Poly(I:C) is a toll-like receptor 3 dsRNA inflammatory stimulant. | Definition | ChEBI: A mismatched double-stranded RNA with one strand being a polymer of inosinic acid, the other a polymer of cytidylic acid. | Biological Activity | poly (i:c), a synthetic double-stranded rna (dsrna) analog, is an immunostimulant that acts as the most potent interferon (ifn) inducer. toll-like receptor- 3 (tlr3) agonist[1].mixtures that included the tlr7/8 agonists r848 or cl075, combined with the poly (i:c), yield 3-d mature dendritic cells [2].commonly used to stimulate immune system activation in vivo. also promotes maturation of hpsc-derived cardiomyocytes[3].[1]. li y g, siripanyaphinyo u, tumkosit u, et al. poly (i:c), an agonist of toll-like receptor-3, inhibits replication of the chikungunya virus in beas-2b cells. virology journal, 2012, 9(1): 114.[2]. spranger s, javorovic m, burdek m, et al. generation of th1-polarizing dendritic cells using the tlr7/8 agonist cl075. the journal of immunology, 2010, 185(1): 738-747.[3]. biermann m1, cai w2, lang d, et al. epigenetic priming of human pluripotent stem cell-derived cardiac progenitor cells accelerates cardiomyocyte maturation. stem cells, 2019, 37(7): 910-923. | in vivo | Polyinosinic-polycytidylic acid (2.5-10 mg/mL, Stereotaxic injection, single dose) induces a sustained inflammatory reaction in the substantia nigra (SN) and in the dorsolateral striatum. [2].
Polyinosinic-polycytidylic acid (10 μg/mouse, Intraperitoneal injection, single dose) decreases lung tumor growth in mice[3].
Polyinosinic-polycytidylic acid (1.25 mg/kg, Intraperitoneal injection, single dose) exerts therapeutic effects against cerebral I/R injury through the downregulation of TLR4/MyD88 signaling via TLR3 in MCAO model mice[5]. Animal Model: | lung tumor-bearing mice[3] | Dosage: | 10 μg/mouse | Administration: | Intraperitoneal injection (i.p.) | Result: | Induced a significant decrease in the growth of pulmonary metastases in tumor-bearing mice.
Reduced the amount of lung foci to ≈ 40%.
Significantly increased BAL fluid cell numbers.
Increased the level of INF-γ and IL-17A, decreased the levels of IL-13.
Increased TLR3 expression. |
Animal Model: | Middle cerebral artery occlusion (MCAO) model mice[5] | Dosage: | 1.25 mg/kg | Administration: | Intraperitoneal injection (i.p.) | Result: | Reduced focal cerebral I/R injury.
Increased the expression of Bcl2, Hsp27, and Hsp70, decreased Bax expression, and reduced cellular degeneration and apoptosis.
Protected against cerebral ischemia and conferred protection against cerebral I/R injury through the downregulation of TLR4 signaling via TLR3. |
| IC 50 | Bcl-2; Bax; IL-17A; IL-13; HSP70 |
| Polyinosinic acid-polycytidylic acid Preparation Products And Raw materials |
|